<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="15318">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02907463</url>
  </required_header>
  <id_info>
    <org_study_id>2015-05</org_study_id>
    <nct_id>NCT02907463</nct_id>
  </id_info>
  <brief_title>EDWARDS INTUITY Elite Valve System</brief_title>
  <acronym>MISSION</acronym>
  <official_title>Assessing Clinical Outcomes Using the EDWARDS INTUITY Elite Valve System in Isolated AVR Using Minimally InvaSive Surgery In a EurOpean Multi-ceNter, Active, Post-market Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Edwards Lifesciences</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Edwards Lifesciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this active, observational, open-label, non-randomized, post-market
      surveillance study is to confirm that EDWARDS INTUITY Elite reduces cross clamp time (XCT)
      in MIS setting when compared to published data with a conventional valve within the MIS
      setting. The published dataset will used as a control group. Then to describe short term (30
      days) and long term (6 months) clinical safety, to assess and compare hemodynamic data with
      EDWARDS INTUITY Elite to a conventional valve at discharge and at 6 months post AVR, to
      assess Quality of Life at baseline, and at 6 months post AVR to assess NYHA functional class
      at baseline, discharge, 1 month and at 6 months post AVR to assess Fitness for hospital
      discharge.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aortic valve replacement with mechanical or biological heart valves is the treatment of
      choice for aortic valve stenosis. Over the past several years, life expectancy has increased
      in industrial nations, but this has been accompanied by a rising rate of elderly patients
      with multiple illnesses.

      Aortic stenosis remains the most common cause of adult valvular heart disease, the
      prevalence increasing with age. Average survival of patients treated conservatively has
      historically been reported as 2—5 years from the onset of symptoms. More recent studies have
      confirmed the dismal prognosis of severe aortic stenosis. Advanced age, reduced
      left-ventricular ejection fraction, congestive heart failure and renal insufficiency appear
      to be independent predictors of reduced survival. Asymptomatic patients with very severe
      aortic stenosis also share a poor prognosis with a high event rate and a risk of rapid
      functional deterioration. Early surgery offers a therapeutic option to improve clinical
      outcomes via decreasing cardiac mortality and improving symptoms.

      Bioprostheses offer several advantages over mechanical bioprostheses, the most important
      being freedom from anticoagulation with a low rate of thromboembolic accidents.

      In response to clinical need and in support of advances in minimally invasive surgical
      approaches to conventional AVR, Edwards Lifesciences developed the EDWARDS INTUITY Elite
      Valve System to achieve clinical benefits by reducing cardiopulmonary bypass and cross clamp
      times, while facilitating a less invasive approach to aortic valve replacement.

      The system includes the EDWARDS INTUITY Elite Valve System, Model 8300AB and the EDWARDS
      INTUITY Elite Delivery System, Model 8300DB; the valve is based on prior heart valve designs
      which have a long history of safety and effectiveness and have incorporated additional
      features designed to improve patient outcomes and safety.

      With only 3 guiding sutures and secure balloon expandable frame, the EDWARDS INTUITY Elite
      Valve system is well suited for smaller incisions and tight access, with an emphasis on
      procedural efficiency within existing operating suite of the surgeon.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cross Clamp Time</measure>
    <time_frame>During the surgical procedure, an expected average of 45 minutes.</time_frame>
    <description>Time during which the blood circulating will be stopped during the procedure: from the aortic clamp start until the aortic clamp removal, an expected average of 45 minutes.
technical success if the subject leaves the Operating Room with the EDWARDS INTUITY Elite valve in place.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Operative Adverse Events</measure>
    <time_frame>The operative data that will be collected during the procedure, time estimated in average 3-4 hours. Additional information will be collected at 30 days and 6 months follow-up visits.</time_frame>
    <description>Post operative cardiac related events that resulted in medical or surgical intervention; all other serious adverse events occurring will be collected as well.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Aortic Valve Disease</condition>
  <condition>Aortic Stenosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        -  Adult subjects, age18 or older, that have been diagnosed with aortic stenosis or
             stenosis-based insufficiency requiring isolated aortic valve replacement (AVR)

          -  Subjects whose medical records indicate they are a suitable candidate for Minimally
             Invasive Surgery (MIS)

          -  Subjects whose treating physician is the Principle Investigator or a Sub-Investigator
             participating in the study and has been trained on the EDWARDS INTUITY Elite Valve
             System

          -  Subject shall be drawn from the general patient population served by each
             investigational center

          -  Candidates for this study must meet all of the following Inclusion criteria and none
             of the Exclusion criteria or intra-op exclusion criteria
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject is 18 years or older

          2. Subject is symptomatic for aortic stenosis (AS) or mixed aortic stenosis and aortic
             insufficiency (AS/AI) disease for which isolated surgical aortic valve replacement
             without concomitant procedures is indicated according to International guidelines.

          3. Surgery starts with and is intended to be completed via a minimal invasive surgical
             approach. MIS is defined as a non-full sternotomy approach such as partial
             hemi-sternotomy, right anterior thoracotomy.

          4. Surgery is intended to be completed with an EDWARDS INTUITY Elite Heart Valve.

          5. Subject has signed and dated the investigation informed consent forms prior to any
             study-specific procedures are performed.

          6. Subject is geographically stable and agrees to attend follow-up assessments as
             specified in the protocol and informed consent.

        Exclusion Criteria:

          1. Subject is diagnosed with pure aortic insufficiency.

          2. Subject requires multiple valve replacement/repair

          3. Subject has Type 0 congenital true bicuspid aortic valve (i.e. absence of raphe and
             commissures are positioned about 180 degrees apart) or unicuspid aortic valve.

          4. Subject has severe ventricular dysfunction defined as LVEF &lt; 25%.

          5. Subject has a history of active endocarditis and/or myocarditis ≤ 3 months before the
             intended treatment/scheduled surgery.

          6. Subject has had an acute MI ≤ 3 months before the intended treatment.

          7. Subject had a stroke or transient ischemic attack within six months prior to
             scheduled aortic valve replacement surgery.

          8. Subject is oxygen or ventilator dependent.

          9. Subject has life expectancy &lt; 12 months.

         10. Female subject is pregnant or lactating.

         11. Subject with documented leukopenia (WBC &lt; 3.5x 103/μL), anemia (Hb &lt; 10.0 gm/dL or &lt;
             6.2 mmol/L), thrombocytopenia (platelet count &lt; 100x 103/mL), or history of bleeding
             diathesis or coagulopathy.

         12. Subject has renal insufficiency as determined by Serum creatinine

             ≥ 200 μmol/L (2.27 mg/dL) at screening or end-stage renal disease requiring chronic
             dialysis.

         13. Subject is currently participating in an investigational drug or device trial for
             which follow-up has not yet been completed.

         14. Minimally Invasive access to the heart is not possible due to anatomical constraints
             or any other pre-existing condition.

         15. Aneurysm of the aortic root and/or ascending aorta

        Intra-operative exclusion criteria:

          1. Subject has Type 0 congenital true bicuspid aortic valve (i.e. absence of raphe and
             commissures are positioned about 180 degrees apart) or unicuspid aortic valve. (A
             non-congenital bicuspid valve without a distorted annulus would not be cause for
             exclusion.)

          2. Subject has calcium on the anterior mitral leaflet which cannot be removed.

          3. Subject has extensive calcification of the aortic root.

          4. Annular deformation which may or may not be caused by too extensive decalcification
             of the aortic annulus.

          5. The position of the coronary ostia relative to the EDWARDS INTUITY Elite Aortic Valve
             could result in obstruction of blood flow.

          6. Minimally Invasive access to the heart is not possible due to anatomical constraints
             or any other condition (including patient switched to a full sternotomy approach).

          7. The device is not available in the correct size for the subject.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christopher Young, MD FRCS</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Thomas' Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gunther Laufer, Prof. Dr. med</last_name>
    <role>Principal Investigator</role>
    <affiliation>AKH Vienna Dep. of Cardiovascular Surgery</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Isabelle Buffin, PharmD</last_name>
    <phone>+ 41 22 787 4313</phone>
    <email>Isabelle_buffin@edwards.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christophe Giot, MD</last_name>
    <phone>+41 22 787 436</phone>
    <email>christophe_giot@edwards.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Universitätsklinik für Herzchirurgie Medizinische Universität Innsbruck</name>
      <address>
        <city>Innsbruck</city>
        <zip>6020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Thomas Schachner, Ao.Univ.Prof.Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinisshe Abteiluing Für Herz-thoraxchirurgie</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dijana Barbaric, Administrative Coordinator</last_name>
      <phone>+43 1 40400 69890</phone>
      <email>Dijana.Barbaric@meduniwien.ac.at</email>
    </contact>
    <contact_backup>
      <last_name>Shiva Shabanian, MSC clinical Research</last_name>
      <phone>+43 678 12 13 748</phone>
      <email>Shabanian.shiva@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Martin Andreas, Ass. Prof. MD, MBA, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aarhus Universitets Hospital Skejby</name>
      <address>
        <city>Aarhus N</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahmad Khalil, Doctor</last_name>
      <phone>+4525754228</phone>
      <email>khalahma@rm.dk</email>
    </contact>
    <contact_backup>
      <last_name>Mariann Tang, Doctor</last_name>
      <phone>+4522450528</phone>
      <email>Mariann.tang@ki.au.dk</email>
    </contact_backup>
    <investigator>
      <last_name>Alan Kim Terp, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Bocage Central Dijon</name>
      <address>
        <city>Dijon</city>
        <zip>21074</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Laubriet-Jazayeri, PhD</last_name>
      <phone>+33380281294</phone>
      <email>Aline.laubriet@chu-dijon.fr</email>
    </contact>
    <investigator>
      <last_name>Olivier Bouchot, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Cardiologique CHU Bordeaux Haut Leveque</name>
      <address>
        <city>Pessac Cedex</city>
        <zip>33 604</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valerie Goin-Monsinjon</last_name>
      <phone>+335 576 562 98</phone>
      <email>valerie.goin@chu-bordeaux.fr</email>
    </contact>
    <contact_backup>
      <last_name>Cécile Joré</last_name>
      <phone>+33 5 5765 66 66</phone>
      <email>Cecile.jore@chu-brodeaux.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Louis Labrousse, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Herz- und Gefäß-Klinik GmbH Bad Neustadt</name>
      <address>
        <city>Bad Neustadt</city>
        <zip>97616</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monika Back, Study Nurse</last_name>
      <phone>+499771662613</phone>
      <email>Monika.back@herzchirurgie.de</email>
    </contact>
    <investigator>
      <last_name>Anno Diegeler, Prof. Dr med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum der Ruhr-Universität Bochum Klinik für Herz- und Thoraxchirurgie</name>
      <address>
        <city>Bochum</city>
        <zip>44789</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bärbel Buchwald, Study Nurse</last_name>
      <phone>+49 234 302 3852</phone>
      <email>baerbel.buchwald@bergmannsheil.de</email>
    </contact>
    <investigator>
      <last_name>Justus Strauch, Prof. Dr med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Herzzentrum Uniklinik Köln</name>
      <address>
        <city>Cologne</city>
        <zip>50924</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Madlen Eichler, Study Nurse</last_name>
      <phone>+49 221 478 32710</phone>
      <email>madlen.eichler@uk-koeln.de</email>
    </contact>
    <investigator>
      <last_name>Thorsten Wahlers, Univ. Prof. Dr med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kerstin Przybilla</last_name>
      <phone>+49 0511 532 5061</phone>
      <email>Przybilla.Kerstin@mh-hannover.de</email>
    </contact>
    <contact_backup>
      <last_name>Stefanie Zimmerman</last_name>
      <phone>+49 511 532 5061</phone>
      <email>Zimmermann.Stefanie@mh-hannover.de</email>
    </contact_backup>
    <investigator>
      <last_name>Malakh Shrestha, Professor Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Herzzentrum Leipzig</name>
      <address>
        <city>Leipzig</city>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anne-Kathrin Funkat, Head of Study coordinators</last_name>
      <phone>+49 (0) 341 865 1571</phone>
      <email>Anne-Kathrin.Funkat@helios-kliniken.de</email>
    </contact>
    <investigator>
      <last_name>David Holzhey, Prof. Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin Klinik und Poliklinik für Herz-, Thorax- und Gefäßchirurgie</name>
      <address>
        <city>Mainz</city>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Irem Karliova, Dr. med.</last_name>
      <phone>0049 6131 - 17 2106</phone>
      <email>iremkarliova@web.de</email>
    </contact>
    <investigator>
      <last_name>Christian Vahl, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Würzburg</name>
      <address>
        <city>Wurzburg</city>
        <zip>97080</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mehmet Oekur, Dr med</last_name>
      <email>Oezkur_M@ukw.de</email>
    </contact>
    <investigator>
      <last_name>Rainer Leyh, Prof. Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>G. Pasquinucci Heart Hospital - &quot;G.Monasterio&quot; Foundation</name>
      <address>
        <city>Massa</city>
        <zip>54100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alessandra Parlanti, Doctor</last_name>
      <phone>+34 0585493675</phone>
      <email>parlantialessandra@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Francesca Chiaramonti, MD</last_name>
      <phone>+3922002667</phone>
      <email>Francesca.chiaramonti@ftgm.it</email>
    </contact_backup>
    <investigator>
      <last_name>Marco Solinas</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Instituto Clinico S. Ambrogio</name>
      <address>
        <city>Milano</city>
        <zip>20149</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Mattia Glauber, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CentroCardiologico Monzino</name>
      <address>
        <city>Milan</city>
        <zip>20138</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eleonora Penza</last_name>
      <phone>+393351241685</phone>
      <email>Eleonora.penza@ccfm.it</email>
    </contact>
    <investigator>
      <last_name>Franco Alamanni, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gian Luca Polvani, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinica San Gaudenzio</name>
      <address>
        <city>Novara</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Orizio</last_name>
      <phone>+39 339 6022446</phone>
      <email>Anna.orizio@clinicasangaudenzio.com</email>
    </contact>
    <investigator>
      <last_name>Gian L Martinelli, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Università Cattolica del Sacro Cuore Policlinico</name>
      <address>
        <city>Roma</city>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marialisa Nesta, Doctor</last_name>
      <phone>+39 0630154639</phone>
      <email>Marialisa85@libero.it</email>
    </contact>
    <investigator>
      <last_name>Massimo Massetti, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero-Universitaria &quot;Santa Maria della Misericordia&quot;</name>
      <address>
        <city>Udine</city>
        <zip>33100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Enzo Mazzaro, Doctor</last_name>
      <phone>+39 340 285 8497</phone>
      <email>Enzo.mazzaro@virgilio.it</email>
    </contact>
    <investigator>
      <last_name>Ugolino Livi, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut National de Chirurgie Cardiaque et Cardiologie Interventionnelle (INCCI)</name>
      <address>
        <city>Luxemburg</city>
        <zip>1210</zip>
        <country>Luxembourg</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie Heinen, Doctor</last_name>
      <phone>+352 2625 5071</phone>
      <email>Kikou22@hotmail.de</email>
    </contact>
    <contact_backup>
      <last_name>Elisabeth Camus</last_name>
      <phone>+352 26 25-5056</phone>
      <phone_ext>5646</phone_ext>
      <email>Camus.Elisabeth@incci.lu</email>
    </contact_backup>
    <investigator>
      <last_name>Khaled Chalabi, Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St Antonius Hospital</name>
      <address>
        <city>Nieuwegein</city>
        <zip>3430 EM / PO BOX 2500</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Idserd Klop</last_name>
      <phone>+31630411909</phone>
      <email>i.klop@antoniusziekenhuis.nl</email>
    </contact>
    <investigator>
      <last_name>Patrick Klein, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Medical Center Ljubljana</name>
      <address>
        <city>Ljubljana</city>
        <zip>1000</zip>
        <country>Slovenia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Matija Jelenc</last_name>
      <phone>+38615224941</phone>
      <email>Matija.jelenc@kclj.si</email>
    </contact>
    <investigator>
      <last_name>Tomislav Klokocovnik, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen de la Arrixaca</name>
      <address>
        <city>El Palmar (Murcia)</city>
        <zip>30120</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Veliz, BSc.</last_name>
      <phone>+34 660 640 277</phone>
      <email>andreaveliz19@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>José Arribas Leal, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complexo Hospitalario Universitario A Coruna</name>
      <address>
        <city>La Coruna</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Victor Bautista, MD</last_name>
      <email>Victor.bautista.hernandez@sergas.es</email>
    </contact>
    <investigator>
      <last_name>Victor Bautista</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico San Carlos</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manuel Carnero, Doctor</last_name>
      <phone>+34 646 773 287</phone>
      <email>mcarnero@me.com</email>
    </contact>
    <investigator>
      <last_name>Luis Maroto, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Infirmary Hospital Edinburgh</name>
      <address>
        <city>Edinburgh</city>
        <zip>EH16 4SA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pandelis Athina</last_name>
      <phone>+ 44 0 131 242 3952</phone>
      <email>Athina.Pandelis@nhslothian.scot.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Renzo MD Pessoto</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St Thomas' Hospital</name>
      <address>
        <city>London</city>
        <zip>SE1 7EH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Wilson</last_name>
      <phone>+442071881093</phone>
      <email>karen.wilson@gstt.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Christopher Young, MD FRCS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Denmark</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Luxembourg</country>
    <country>Netherlands</country>
    <country>Slovenia</country>
    <country>Spain</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 22, 2017</lastchanged_date>
  <firstreceived_date>June 29, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Aortic Valve Replacement</keyword>
  <keyword>Aortic Stenosis</keyword>
  <keyword>EDWARDS INTUITY Elite</keyword>
  <keyword>Rapid deployment valves</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
